These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 32402575

  • 1. D-dimer as A Biomarker of Severity and Adverse Outcomes in Patients with Community Acquired Pneumonia.
    Cerda-Mancillas MC, Santiago-Germán D, Andrade-Bravo B, Pedraza-Olivares F, Valenzo-Hernández F, Leaños-Miranda A, Isordia-Salas I.
    Arch Med Res; 2020 Jul; 51(5):429-435. PubMed ID: 32402575
    [Abstract] [Full Text] [Related]

  • 2. Admission D-dimer can identify low-risk patients with community-acquired pneumonia.
    Chalmers JD, Singanayagam A, Scally C, Hill AT.
    Ann Emerg Med; 2009 May; 53(5):633-8. PubMed ID: 19201061
    [Abstract] [Full Text] [Related]

  • 3. [Coagulopathy correlates with outcomes in patients with community- acquired pneumonia].
    Zhuang Q, Zeng Y, Shi Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):406-10. PubMed ID: 25200038
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of D-dimer in predicting mortality in patients with community-acquired pneumonia.
    Nastasijević Borovac D, Radjenović Petković T, Pejčić T, Stanković I, Janković I, Ćirić Z, Rančić M.
    Med Glas (Zenica); 2014 Feb; 11(1):37-43. PubMed ID: 24496339
    [Abstract] [Full Text] [Related]

  • 7. The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study.
    Dai RX, Kong QH, Mao B, Xu W, Tao RJ, Wang XR, Kong QY, Xu JF.
    BMC Pulm Med; 2018 Jan 22; 18(1):12. PubMed ID: 29357862
    [Abstract] [Full Text] [Related]

  • 8. [Prognostic and stratified value of adrenomedullin in community acquired pneumonia patients in emergency department].
    Chen Y, Li C.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Feb 22; 26(2):115-9. PubMed ID: 24524403
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial.
    Snijders D, Schoorl M, Schoorl M, Bartels PC, van der Werf TS, Boersma WG.
    Eur J Intern Med; 2012 Jul 22; 23(5):436-41. PubMed ID: 22726372
    [Abstract] [Full Text] [Related]

  • 11. Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia.
    Querol-Ribelles JM, Tenias JM, Grau E, Querol-Borras JM, Climent JL, Gomez E, Martinez I.
    Chest; 2004 Oct 22; 126(4):1087-92. PubMed ID: 15486368
    [Abstract] [Full Text] [Related]

  • 12. Value of D-dimer in predicting various clinical outcomes following community-acquired pneumonia: A network meta-analysis.
    Li J, Zhou K, Duan H, Yue P, Zheng X, Liu L, Liao H, Wu J, Li J, Hua Y, Li Y.
    PLoS One; 2022 Oct 22; 17(2):e0263215. PubMed ID: 35196337
    [Abstract] [Full Text] [Related]

  • 13. On-admission level of serum d-dimer and the severity of community-acquired pneumonia.
    Mikaeilli H, Zarghami N, Yazdchi M, Mardani M, Ansarin K.
    Pak J Biol Sci; 2009 Mar 15; 12(6):514-7. PubMed ID: 19580001
    [Abstract] [Full Text] [Related]

  • 14. The association between plasma D-dimer levels and community-acquired pneumonia.
    Arslan S, Ugurlu S, Bulut G, Akkurt I.
    Clinics (Sao Paulo); 2010 Jun 15; 65(6):593-7. PubMed ID: 20613935
    [Abstract] [Full Text] [Related]

  • 15. Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia.
    Bradley J, Sbaih N, Chandler TR, Furmanek S, Ramirez JA, Cavallazzi R.
    Chest; 2022 Apr 15; 161(4):927-936. PubMed ID: 34740594
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP, Capelastegui A, Mar C, Bilbao A, Quintana JM, Diez R, Esteban C, Bereciartua E, Unanue U, Uranga A.
    J Infect; 2015 May 15; 70(5):457-66. PubMed ID: 25499199
    [Abstract] [Full Text] [Related]

  • 18. Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia.
    Lee JH, Chung HJ, Kim K, Jo YH, Rhee JE, Kim YJ, Kang KW.
    Am J Emerg Med; 2013 Jan 15; 31(1):72-9. PubMed ID: 22867824
    [Abstract] [Full Text] [Related]

  • 19. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia.
    Yandiola PPE, Capelastegui A, Quintana J, Diez R, Gorordo I, Bilbao A, Zalacain R, Menendez R, Torres A.
    Chest; 2009 Jun 15; 135(6):1572-1579. PubMed ID: 19141524
    [Abstract] [Full Text] [Related]

  • 20. A Prospective Study of Presepsin as an Indicator of the Severity of Community-Acquired Pneumonia in Emergency Departments: Comparison with Pneumonia Severity Index and CURB-65 Scores.
    Ham JY, Song KE.
    Lab Med; 2019 Oct 10; 50(4):364-369. PubMed ID: 30892617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.